Perceptive in licensing deal with EurQol

12 January 2009

Boston, USA-based Perceptive Informatics, an e-Clinical solutions provider and subsidiary of Parexel International, has entered into a  license agreement with the EuroQoL Group. This allows Perceptive to  provide EQ-5D, a standardized instrument to measure health-related  quality of life outcomes, through its Electronic Patient Reported  Outcomes solution in an Interactive Voice Response format. Perceptive  Informatics says it is among the first organizations in the industry to  offer the EQ-5D instrument in an ePRO-IVR format.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight